EBO honours renowned Italian ophthalmologist
Costantino Bianchi honoured with Peter Eustace Medal


Colin Kerr
Published: Friday, July 6, 2018
The renowned Italian ophthalmologist Costantino Bianchi was posthumously honoured at the European Board of Ophthalmology (EBO) Diploma Award Ceremony as the recipient of the Peter Eustace Medal for his contribution to ophthalmic education in Europe.
“Dr Bianchi sadly passed away last year but his legacy in terms of his achievements in Italian and European ophthalmology will continue to inspire those who follow in his footsteps,” said Gordana Sunaric Mégevand, President of EBO.
Born in Bergamo in 1940, Dr Bianchi began his career in ophthalmology after graduating in medicine from the University of Milan in 1969. He established his own eye clinic in Milan and established a national and international reputation for his research in refraction, tear film diagnosis and as a developer of instruments for corneal topography.
From 1985 to 2005, he served as professor of ocular pathology at the Optometry Institute in Lombardy, followed by a stint at the University of Siena from 2005 until shortly before his death. Dr Bianchi was an active member of several scientific societies in Italy and abroad, serving as Italian delegate to the Ophthalmic section of the European Union of Medical Specialists (UEMS) from 2000 and Italian delegate to the EBO from 2000 to 2008.
As well as being the lead author of many peer-reviewed publications, Dr Bianchi was founder and director of the ocular microsurgery magazine Viscochirurgia, and went on to edit several ophthalmological publications during his long and distinguished career.
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.
Should Fuchs’ Dystrophy Patients Get Premium Lenses?
Patients’ demand for premium IOLs despite contraindications pose a challenge in Fuchs’ dystrophy treatment.
Avoiding Posterior Capsule Rupture
Imaging may help, but surgical technique is key for managing posterior polar cataracts.